A simple stereocontrolled synthesis of salinosporamide A

Journal of the American Chemical Society

Volumn 126, Issue 20, 2004, Pages 6230-6231

  Reddy, Leleti Rajender ^a   Saravanan, P ^a   Corey, E J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LACTACYSTIN BETA LACTONE; NATURAL PRODUCT; SALINOSPORAMIDE A; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; INDICATORS AND REAGENTS; LACTONES; MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL ROTATION; PYRROLES; SPECTROPHOTOMETRY, INFRARED; STEREOISOMERISM;

EID: 2442720189     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja048613p     Document Type: Article

References (19)

1. Feling, R. H.; Buchanan, G. O.; Mincer, T. J.; Kauffman, C. A.; Jensen, P. R.; Fenical, W. Angew. Chem., Int. Ed. 2003, 42, 355-357.
2. (a) Reviewed in: Corey, E. J.; Li, W.-D. Z. Chem. Pharm. Bull. 1999, 47, 1-10.
3. (b) Corey, E. J.; Reichard, G. A.; Kania, R. Tetrahedron Lett. 1993, 34, 6977-6980.
4. (c) Corey, E. J.; Reichard, G. A. J. Am. Chem. Soc. 1992, 114, 10677-10678.
5. (d) Fenteany, G.; Standaert, R. F.; Reichard, G. A.; Corey, E. J.; Schreiber, S. L. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3358-3362.
6. (a) Omura, S.; Fujimoto, T.; Otoguro, K.; Matsuzaki, K.; Moriguchi, R.; Tanaka, H.; Sasaki, Y. J. Antibiot. 1991, 44, 113-116.
7. (b) Omura, S.; Matsuzaki, K.; Fujimoto, T.; Kosuge, K.; Furuya, T.; Fujita, S.; Nakagawa, A. J. Antibiot. 1991, 44, 117-118.
8. (a) Frank, S. A.; Mergott, D. J.; Roush, W. R. J. Am. Chem. Soc. 2002, 124, 2404-2405.
9. (b) Mergott, D. J.; Frank, S. A.; Roush, W. R. Org. Lett. 2002, 4, 3157-3160.
10. (c) Aggarwal, V. K.; Emme, I.; Fulford, S. Y. J. Org. Chem. 2003, 68, 692-700.
11. (d) Yeo, J. E.; Yang, X.; Kim, H. J.; Koo, S. J. Chem. Soc., Chem. Commun. 2004, 236-237.
12. (a) Bols, M.; Skrydstrup, T. Chem. Rev. 1995, 95, 1253-1277.
13. (b) Fleming, I.; Barbero, A.; Walter, D. Chem. Rev. 1997, 97, 2063-2092.
14. (c) Stork, G.; Mook, R.; Biller, S. A.; Rychnovsky, S. D. J. Am. Chem. Soc. 1983, 105, 3741-3742.
15. (d) Stork, G.; Sher, P. M.; Chen, H. L. J. Am. Chem. Soc. 1986, 108, 6384-6385.
16. Miyake, H.; Yamamura, K. Chem. Lett. 1992, 507-508.
17. The stereochemistry of the conversion 13 → 14, established by the identity of totally synthetic 1 with naturally formed salinosporamide A, is that predicted from a cyclic, chair-formed, six-membered transition state involving addition of the organozinc reagent to the sterically more accessible face of the formyl group. The use of 2-cyclohexenylzinc chloride is critical to successful formation of 14 because none of this product is obtained with 2-cyclohexenyllithium (probably because the initial carbonyl adduct undergoes retroaldol cleavage and decomposition; see: Corey, E. J.; Li, W.; Nagamitsu, T. Angew. Chem., Int. Ed. 1998, 37, 1676-1679).
18. (a) Fleming, I. Chemtracts-Org. Chem. 1996, 9, 1-64.
19. (b) Jones, G. R.; Landais, Y. Tetrahedron 1996, 52, 7599-7662.